Crystal structure of opsin in its G-protein-interacting conformation
The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Opsin, the ligand-free form of the G-protein-coupled receptor rhodopsin, at low pH adopts a conformationally distinct, active G-protein-binding state known as Ops*. A synthetic peptide derived from the main binding site of the heterotrimeric G protein-the carboxy terminus of the alpha-subunit (GalphaCT)-stabilizes Ops*. Here we present the 3.2 A crystal structure of the bovine Ops*-GalphaCT peptide complex. GalphaCT binds to a site in opsin that is opened by an outward tilt of transmembrane helix (TM) 6, a pairing of TM5 and TM6, and a restructured TM7-helix 8 kink. Contacts along the inner surface of TM5 and TM6 induce an alpha-helical conformation in GalphaCT with a C-terminal reverse turn. Main-chain carbonyl groups in the reverse turn constitute the centre of a hydrogen-bonded network, which links the two receptor regions containing the conserved E(D)RY and NPxxY(x)(5,6)F motifs. On the basis of the Ops*-GalphaCT structure and known conformational changes in Galpha, we discuss signal transfer from the receptor to the G protein nucleotide-binding site.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The crystal structure of opsin,370 an opsin structure with another retinoid bound,371 and mutagenesis studies372 all suggest an escape and entrance route for retinal.”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [370]
Citations
Cites
1 retracted
Johnston, C. A., & Siderovski, D. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608599104 · Cited by 38
Retracted[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Cited by
Items 201–300 of 1,000
Baud, O., Etter, S., Spreafico, M., Bordoli, L., Schwede, T., Vogel, H., & Pick, H. (2011) · Biochemistry · doi:10.1021/bi1017396 · Cited by 88
G protein-coupled receptors: the evolution of structural insight
Gacasan, S. B., Baker, D. L., & Parrill, A. L. (2017) · AIMS Biophysics · doi:10.3934/biophy.2017.3.491 · Cited by 104
Miao, Y., Caliman, A. D., & McCammon, J. A. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.03.003 · Cited by 88
“Different displacement magnitudes of the TM6 cytoplasmic end have also been observed in the active x-ray structures of opsin (~6–7 Å) (7,8), b2AR coupled by the Gs protein (14 Å) (11), and a G-protein mimetic nanobody (11.”
BackgroundInfluentialZhang, P., Gruber, A., Kasuda, S., Kimmelstiel, C. D., O’Callaghan, K., Cox, D. H., Bohm, A., Baleja, J., Covic, L., & Kuliopulos, A. (2012) · Circulation · doi:10.1161/circulationaha.112.091918 · Cited by 88
Structure and activation of rhodopsin
Zhou, X. E., Melcher, K., & Xu, H. E. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.171 · Cited by 87
“During the thermal relaxation, the protein moiety of rhodopsin undergoes a series of conformational changes that lead to the formation of a G protein binding site on the cytoplasmic side of the 7TM bundle[7–11] (Figure 2D and 2E).”
BackgroundInfluentialWright, S. C., Kozielewicz, P., Kowalski-Jahn, M., Petersen, J., Bowin, C.-F., Slodkowicz, G., Marti-Solano, M., Rodríguez, D., Hot, B., Okashah, N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08630-2 · Cited by 84
Structure-Function Relationships of the Follicle-Stimulating Hormone Receptor
Ulloa‐Aguirre, A., Zariñán, T., Jardón‐Valadez, E., Gutiérrez‐Sagal, R., & Dias, J. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00707 · Cited by 92
“A ligand-free form of opsin that is co-crystalized with the carboxyl-terminus of the α-subunit of Gαt (99); b.”
BackgroundTam, B. M., & Moritz, O. L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4259-09.2009 · Cited by 97
“According to crystal structures, no gross conformational changes are reported for the N terminus of opsin during chromophore binding or light activation (Salom et al., 2006; Park et al., 2008; Scheerer et al., 2008), suggesting that this domain remains relatively static.”
From G Protein-coupled Receptor Structure Resolution to Rational Drug Design
Jazayeri, A., Dias, J. M., & Marshall, F. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.668251 · Cited by 85
“The first sight of structural changes underpinning receptor activation came from the resolution of opsin in complex with the C-terminal fragment of the -subunit of transducin (the light transduction heterotrimeric G protein) (29).”
BackgroundJacobson, K. A., & Costanzi, S. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.079335 · Cited by 85
“, -adrenergic and adenosine receptors, in addition to visual pigment receptors with the structures of opsin and rhodopsin) (Park et al., 2008; Scheerer et al., 2008; Choe et al., 2011; Rasmussen et al., 2011a,b; Standfuss et al., 2011; Xu et al., 2011).”
BackgroundMethodTsai, C., Pamula, F., Nehmé, R., Mühle, J., Weinert, T., Flock, T., Nogły, P., Edwards, P. C., Carpenter, B., Gruhl, T., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat7052 · Cited by 86
A New Drug Design Targeting the Adenosinergic System for Huntington's Disease
Huang, N.-K., Lin, J.-H., Lin, J.-T., Lin, C.-I., Liu, E. M., Lin, C.-J., Chen, W.-P., Shen, Y.-C., Chen, H.-M., Chen, J.-B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020934 · Cited by 82
“, residues 175,310, were modeled based on the opsin structure [81].”
Ren, H., Yu, D., Ge, B., Cook, B., Xu, Z., & Zhang, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004509 · Cited by 91
“Up to now the molecular structures of only 5 unique GPCRs have been determined including bovine rhodopsin with and without the retinal ligand as well as with a C-terminal 11-residue peptide fragment of a Ga-protein (Ga-CT) [8,9,10]; a highly engineered human b2-adrenergic receptor with a replaced intracellular loop 3…”
BackgroundWorth, C. L., Kleinau, G., & Krause, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007011 · Cited by 102
“The recent publication of the opsin structure [22] and opsin bound to a G-protein derived synthetic peptide [23] represent activated states, providing important information about the structural changes associated with activation of GPCRs.”
BackgroundMolecular Mechanisms of GPCR Signaling: A Structural Perspective
Gurevich, V. V., & Gurevich, E. V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122519 · Cited by 85
“The structural basis for this phenomenon was demonstrated later by solving the co-structures of signaling-competent opsin [40] and opsin-derived all-trans-retinal-liganded Metarhodopsin II [41] with a modified peptide representing the C-terminus of transducin Gα.”
BackgroundStructural basis of G protein–coupled receptor–G protein interactions
Hu, J., Wang, Y., Zhang, X., Lloyd, J. R., Li, J. H., Karpiak, J. D., Costanzi, S., & Wess, J. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.385 · Cited by 84
Molecular mechanisms regulating Proteinase-Activated Receptors (PARs)
Chandrabalan, A., & Ramachandran, R. (2021) · The FEBS Journal · doi:10.1111/febs.15829 · Cited by 83
Perez‐Aguilar, J. M., Shan, J., Levine, M. V., Khelashvili, G., & Weinstein, H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508394x · Cited by 87
Tosh, D. K., Deflorian, F., Phan, K., Gao, Z., Wan, T. C., Gizewski, E. T., Auchampach, J. A., & Jacobson, K. A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300396n · Cited by 83
Effect of channel mutations on the uptake and release of the retinal ligand in opsin
Piechnick, R., Ritter, E., Hildebrand, P. W., Ernst, O. P., Scheerer, P., Hofmann, K. P., & Heck, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117268109 · Cited by 89
“This retinal channel is open in active Meta II and Ops* apoprotein conformations (10, 11, 14, 15) but closed in the 11-cis-retinal bound rhodopsin dark state (28).”
BackgroundSelf-citationDivergent Positive Selection in Rhodopsin from Lake and Riverine Cichlid Fishes
Schott, R. K., Refvik, S. P., Hauser, F. E., López‐Fernández, H., & Chang, B. S. W. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu064 · Cited by 90
Baltoumas, F. A., Theodoropoulou, M. C., & Hamodrakas, S. J. (2013) · Journal of Structural Biology · doi:10.1016/j.jsb.2013.03.004 · Cited by 100
Boughton, A. P., Yang, P., Tesmer, V. M., Ding, B., Tesmer, J. J. G., & Chen, Z. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108236108 · Cited by 81
“For example, the interactions of heterotrimeric G proteins, in particular their βγ subunits (Gβγ), with the lipid bilayer facilitate GPCR-catalyzed GTP exchange on the Gα subunit (5).”
Refining Efficacy: Allosterism and Bias in G Protein-Coupled Receptor Signaling
Luttrell, L. M., & Kenakin, T. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-160-4_1 · Cited by 90
G Protein - Mediated Signaling: Same Receptor, Multiple Effectors
Woehler, A., & Ponimaskin, E. G. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902030237 · Cited by 97
“In the canonical G protein signaling cascade, GPCRs undergo a conformational change upon ligand binding that facilitates interaction between an intracellular domain of the receptor and a heterotrimeric G protein [8-12].”
BackgroundGrossfield, A. M. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.03.010 · Cited by 85
“The closest examples to date are the crystal structures of opsin on its own [14] and with a G protein fragment bound [15].”
BackgroundReversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins
Blazer, L. L., Roman, D. L., Chung, A., Larsen, M. J., Greedy, B. M., Husbands, S. M., & Neubig, R. R. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065128 · Cited by 91
Endocrinology and the brain: corticotropin-releasing hormone signaling
Inda, C., Armando, N. G., Claro, P. A. D. S., & Silberstein, S. (2017) · Endocrine Connections · doi:10.1530/ec-17-0111 · Cited by 89
Highly conserved tyrosine stabilizes the active state of rhodopsin
Goncalves, J. A., South, K., Ahuja, S., Zaitseva, E., Opefi, C. A., Eilers, M., Vogel, R., Reeves, P. J., & Smith, S. O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009405107 · Cited by 80
“Interestingly, in the active opsin structure (12), these residues do not interact directly but rather interact most closely with Cys187EL2 and Glu181EL2, respectively, on EL2.”
Fanelli, F., & Benedetti, P. G. D. (2011) · Chemical Reviews · doi:10.1021/cr100437t · Cited by 82
G i - and G s -coupled GPCRs show different modes of G-protein binding
Eps, N. V., Altenbach, C., Caro, L. N., Latorraca, N. R., Hollingsworth, S. A., Dror, R. O., Ernst, O. P., & Hubbell, W. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721896115 · Cited by 77
Self-citationHow genetic errors in GPCRs affect their function: Possible therapeutic strategies
Stoy, H., & Gurevich, V. V. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.02.005 · Cited by 83
“The complex structure further illustrated the importance of the DRY motif as a central activation motif.(72) In 2011 Rasmussen et al(23) solved the crystal structure of b2AR in complex with Gs protein, providing further definite evidence of receptorG protein interactions.”
BackgroundSchreier, S., Bozelli, J. C., Marín, N., Vieira, R. F. F., & Nakaie, C. R. (2012) · Biophysical Reviews · doi:10.1007/s12551-011-0064-5 · Cited by 77
“In contrast, a narrow distance distribution centered at 19 Å was found for R*-bound Gtα(340-350), consistent with the configuration determined by crystal studies (Scheerer et al. 2008) and by NMR (Kisselev et al. 1998).”
ResultRetinoids in the visual cycle: role of the retinal G protein-coupled receptor
Choi, E. H., Daruwalla, A., Suh, S., Leinonen, H., & Palczewski, K. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000850 · Cited by 84
“When light isomerizes 11-cis-retinal to all-trans-retinal, the all-trans-retinal dissociates from the activated opsin (63, 64) and traverses one of two pathways.”
BackgroundRanganathan, A., Dror, R. O., & Carlsson, J. (2014) · Biochemistry · doi:10.1021/bi5008723 · Cited by 80
Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors
Culhane, K. J., Liu, Y., Cai, Y., & Yan, E. C. Y. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00264 · Cited by 72
Structural Determinants of Arrestin Functions
Gurevich, V. V., & Gurevich, E. V. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394440-5.00003-6 · Cited by 75
Structural mechanism of arrestin activation
Scheerer, P., & Sommer, M. E. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.05.001 · Cited by 89
Self-citationStructure-Based Drug Design for G Protein-Coupled Receptors
Congreve, M., Dias, J. M., & Marshall, F. H. (2014) · Progress in medicinal chemistry · doi:10.1016/b978-0-444-63380-4.00001-9 · Cited by 79
Opsin, a Structural Model for Olfactory Receptors?
Park, J. H., Morizumi, T., Li, Y., Hong, J. E., PAI, E. F., Hofmann, K. P., Choe, H., & Ernst, O. P. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302374 · Cited by 77
Self-citationScott, D. J., & Plückthun, A. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.11.015 · Cited by 74
Costanzi, S., Siegel, J. N., Tikhonova, I. G., & Jacobson, K. A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789824795 · Cited by 83
“As mentioned, recent advances have allowed the crystallization of the unliganded opsin without the presence of the rigidifying chromophore [65,66].”
BackgroundSpatial and Temporal Aspects of Signaling by G-Protein–Coupled Receptors
Lohse, M. J., & Hofmann, K. P. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.100248 · Cited by 84
Self-citationStructurally Enabled Discovery of Adenosine A 2A Receptor Antagonists
Jazayeri, A., Andrews, S. P., & Marshall, F. H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00119 · Cited by 83
Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors
Bartuzi, D., Kaczor, A. A., Targowska‐Duda, K. M., & Matosiuk, D. (2017) · Molecules · doi:10.3390/molecules22020340 · Cited by 78
Evolution of vertebrate retinal photoreception
Lamb, T. D. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0102 · Cited by 73
“From the crystal structure of active bovine opsin, Scheerer et al. (2008) report that E181 stabilizes the activated metarhodopsin during its interaction with the G-protein.”
BackgroundConstitutively Active Rhodopsin and Retinal Disease
Park, P. S.-H. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-417197-8.00001-8 · Cited by 80
“Under acidic conditions or in crystals formed by detergentsolubilized receptor, opsin can achieve a conformation similar to that of the active MII state (Park, Scheerer, Hofmann, Choe, & Ernst, 2008; Scheerer et al., 2008; Vogel & Siebert, 2001).”
BackgroundYoshiura, C., Kofuku, Y., Ueda, T., Mase, Y., Yokogawa, M., Osawa, M., Terashima, Y., Matsushima, K., & Shimada, I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100830f · Cited by 73
Carpenter, B., & Tate, C. G. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.04.010 · Cited by 73
Recurrent convergent evolution at amino acid residue 261 in fish rhodopsin
Hill, J. A., Enbody, E. D., Pettersson, M. E., Sprehn, C. G., Bekkevold, D., Folkvord, A., Laikre, L., Kleinau, G., Scheerer, P., & Andersson, L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908332116 · Cited by 78
Self-citationControl of Iron Metabolism in Bacteria
Andrews, S., Norton, I., Salunkhe, A. S., Goodluck, H., Aly, W. S. M., Mourad-Agha, H., & Cornelis, P. (2013) · Metal Ions in Life Sciences · doi:10.1007/978-94-007-5561-1_7 · Cited by 72
de Graaf, C., Rein, C., Piwnica, D., Giordanetto, F., & Rognan, D. (2011) · ChemMedChem · doi:10.1002/cmdc.201100317 · Cited by 72
Differential association modes of the thrombin receptor PAR 1 with Gαil, Gα12, and β‐arrestin 1
Ayoub, M. A., Trinquet, E., Pfleger, K. D. G., & Pin, J. (2010) · The FASEB Journal · doi:10.1096/fj.10-154997 · Cited by 72
Quantification of Functional Selectivity at the Human α1A-Adrenoceptor
Evans, B. A., Broxton, N. M., Merlin, J., Sato, M., Hutchinson, D. S., Christopoulos, A., & Summers, R. J. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.067454 · Cited by 72
“Furthermore, it has been possible to compare the structures of inactive rhodopsin and its active opsin coun- terpart (Scheerer et al., 2008).”
Liu, T., Li, X., You, S., Bhuyan, S. S., & Dong, L. (2015) · Experimental Hematology and Oncology · doi:10.1186/s40164-016-0050-5 · Cited by 76
“[11, 12] provided strong evidence to the switch theory by crystalizing rhodopsin, presumed to be an active state representation.”
BackgroundGPCR activation: a mutagenic spotlight on crystal structures
Hulme, E. C. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.11.002 · Cited by 71
Huynh, J., Thomas, W. G., Aguilar, M., & Pattenden, L. K. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.01.002 · Cited by 72
Chemistry and Biology of the Initial Steps in Vision: The Friedenwald Lecture
Palczewski, K. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15502 · Cited by 75
Understanding the GPCR biased signaling through G protein and arrestin complex structures
Zhou, X. E., Melcher, K., & Xu, H. E. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.05.004 · Cited by 71
Functional significance of serotonin receptor dimerization
Herrick‐Davis, K. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3622-1 · Cited by 71
“…orientation of potential physiological relevance: rhodopsin (Lodowski et al. 2007; Murakami and Kouyama 2008), B2-AR (Cherezov et al. 2007), opsin (Scheerer et al. 2008), CXCR4 (wu et al. 2010), mu-and kappa-opioid (Manglik et al. 2012; wu et al. 2012), and the recently solved structure for the”
Energetic analysis of the rhodopsin–G-protein complex links the α5 helix to GDP release
Alexander, N. S., Preininger, A. M., Kaya, A. I., Stein, R. A., Hamm, H. E., & Meiler, J. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2705 · Cited by 68
Functional map of arrestin-1 at single amino acid resolution
Ostermaier, M. K., Peterhans, C., Jaussi, R., Deupí, X., & Standfuss, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319402111 · Cited by 68
“As a second anchoring point, beside the phosphorylated C terminus, we placed the finger loop into the central crevice that opens upon activation of rhodopsin and mediates interaction with the C terminus of the Gα subunit (34).”
BackgroundCrystal structure of the endogenous agonist-bound prostanoid receptor EP3
Morimoto, K., Suno, R., Hotta, Y., Yamashita, K., Hirata, K., Yamamoto, M., Narumiya, S., Iwata, S., & Kobayashi, T. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0171-8 · Cited by 68
Orban, T., Jastrzebska, B., Gupta, S., Wang, B., Miyagi, M., Chance, M. R., & Palczewski, K. (2012) · Structure · doi:10.1016/j.str.2012.03.017 · Cited by 67
“Opsin, the chromophore-free form of Rho, adopts an active Gt binding state at low pH, termed opsin* (Scheerer et al., 2008).”
BackgroundInfluentialBusnelli, M., Kleinau, G., Muttenthaler, M., Stoev, S., Manning, M., Bibic, L., Howell, L. A., McCormick, P. J., Di Lascio, S., Braida, D., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00564 · Cited by 67
Constitutive Activity of Neural Melanocortin Receptors
Tao, Y., Huang, H., Wang, Z.-Q., Yang, F., Williams, J. N., & Nikiforovich, G. V. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381298-8.00014-9 · Cited by 68
“The recent X-ray studies revealed the structure of opsin in complex with the C-terminal peptide of transducin stabilizing the photoactivated structure of rhodopsin (Scheerer et al., 2008).”
BackgroundMethodCustomizing G Protein-Coupled Receptor Models for Structure-Based Virtual Screening
de Graaf, C., & Rognan, D. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789824786 · Cited by 67
“Recently, crystal structures of squid rhodopsin, the beta adrenergic receptors type 1 (ADRB1) and 2 (ADRB2), the A2A adenosine receptor (AA2AR), and the ligand-free opsin (Ops*) were solved [10-16].”
BackgroundInfluentialStructural features of adenosine receptors: From crystal to function
Piirainen, H., Ashok, Y., Nanekar, R. T., & Jaakola, V. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.05.021 · Cited by 81
“49) [15–19].”
Structures for G-Protein-Coupled Receptor Tetramers in Complex with G Proteins
Cordomí, A., Navarro, G., Aymerich, M. S., & Franco, R. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.07.007 · Cited by 72
“The crystal structures of the b2AR-Gs complex [6] and of opsin with a G/ C-terminal (Ct)-derived peptide [7] revealed the precise changes (mainly in TMs 5 and 6) required for G/Ct binding (Figure 1B).”
BackgroundSzlenk, C. T., GC, J. B., & Natesan, S. (2019) · Molecular Pharmacology · doi:10.1124/mol.118.115113 · Cited by 71
Schneider, E. H., Schnell, D., Straßer, A., Dove, S., & Seifert, R. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163220 · Cited by 67
“The model of the putative active state of the hH4R was based on an inactive state model (Igel et al., 2009) and the recent crystal structure of opsin in complex with a C-terminal fragment of transducin [Protein Data Bank (PDB) ID no. 3DQB; Scheerer et al., 2008].”
BackgroundMethodInfluentialAllostery in GPCRs: ‘MWC’ revisited
Canals, M., Sexton, P. M., & Christopoulos, A. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.08.005 · Cited by 65
Dimerization and ligand binding affect the structure network of A(2A) adenosine receptor.
Fanelli, F., & Felline, A. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamem.2010.08.006 · Cited by 64
Relevance of rhodopsin studies for GPCR activation
Deupí, X. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.09.002 · Cited by 64
Cherezov, V., Abola, E. E., & Stevens, R. C. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-762-4_8 · Cited by 63
“Recently a crystal structure of the bovine opsin bound to a transducin fragment shed some light on the receptor activation mechanism (18).”
Putative Active States of a Prototypic G-Protein-Coupled Receptor from Biased Molecular Dynamics
Provasi, D., & Filizola, M. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.01.047 · Cited by 63
Use of transmission electron microscopy to identify nanocrystals of challenging protein targets
Stevenson, H. P., Makhov, A. M., Calero, M., Edwards, A. L., Zeldin, O. B., Mathews, I. I., Lin, G., Barnes, C. O., Santamaría, H., Ross, T. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400240111 · Cited by 73
“Changes similar to the active form of Opsin (49) were observed in this structure, showing rearrangement of TM5s and 7 as shown in Figure 5.”
InfluentialStructural biology of G protein‐coupled receptor signaling complexes
Edward Zhou, X., Melcher, K., & Eric Xu, H. (2019) · Protein Science · doi:10.1002/pro.3526 · Cited by 62
Frontiers in Cryo Electron Microscopy of Complex Macromolecular Assemblies
Ognjenović, J., Grisshammer, R., & Subramaniam, S. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-060418-052453 · Cited by 59
Zaitseva, E., Brown, M. F., & Vogel, R. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910317a · Cited by 62
Rhodopsin/Lipid Hydrophobic Matching—Rhodopsin Oligomerization and Function
Soubias, O., Teague, W. E., Hines, K. G., & Gawrisch, K. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.01.006 · Cited by 62
“l D l E l r=l l D l E Sav 1⁄4 Sf þ abx Sb Sf ; (3)”
Sansuk, K., Deupí, X., Torrecillas, I. R., Jongejan, A., Nijmeijer, S., Bakker, R. A., Pardo, L., & Leurs, R. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066068 · Cited by 62
“on these results and on the recent insights into GPCR structure (Park et al., 2008; Scheerer et al., 2008), we propose that the hydrophobic side chain at position 3.”
BackgroundConserved activation pathways in G-protein-coupled receptors
Deupí, X., Standfuss, J., & Schertler, G. F. X. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120001 · Cited by 71
A Small Chaperone Improves Folding and Routing of Rhodopsin Mutants Linked to Inherited Blindness
Behnen, P., Felline, A., Comitato, A., Salvo, M. T. D., Raimondi, F., Gulati, S., Kahremany, S., Palczewski, K., Marigo, V., & Fanelli, F. (2018) · iScience · doi:10.1016/j.isci.2018.05.001 · Cited by 67
Grahl, A., Abiko, L. A., Isogai, S., Sharpe, T., & Grzesiek, S. (2020) · Nature Communications · doi:10.1038/s41467-020-15864-y · Cited by 64
Marelja, Z., Leimkühler, S., & Missirlis, F. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00050 · Cited by 54
“, 2001) and later resolved structures of G-coupled protein receptors and cryptochromes (Scheerer et al., 2008; Choe et al., 2011; Zhang F. et al., 2013; Nagano et al., 2016).”
BackgroundHuang, C.-C., & Tesmer, J. J. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.051847 · Cited by 61
Homology Modeling of Class A G Protein-Coupled Receptors
Costanzi, S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-588-6_11 · Cited by 69
Snooker: A Structure-Based Pharmacophore Generation Tool Applied to Class A GPCRs
Sanders, M. P. A., Verhoeven, S., de Graaf, C., Roumen, L., Vroling, B., Nabuurs, S. B., de Vlieg, J., & Klomp, J. P. G. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200088d · Cited by 60
GPCR agonist binding revealed by modeling and crystallography
Katritch, V., & Abagyan, R. A. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.08.001 · Cited by 60
Lipid modulation of early G protein-coupled receptor signalling events
Dijkman, P. M., & Watts, A. G. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.08.004 · Cited by 60
Periole, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00344 · Cited by 58
Guan, R., Wu, X., Feng, X., Zhang, M., Hébert, T. E., & Segaloff, D. L. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.023 · Cited by 58
Jing, M., Zhang, Y., Wang, H., & Li, Y. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14855 · Cited by 60
“…followed by G protein interaction stabilizes the protein in the active conformation, resulting in downstream signal transduction (Rasmussen et al. 2007; Cherezov et al. 2007; Scheerer et al. 2008; Rasmussen et al. 2011; Venkatakrishnan et al. 2013; Manglik et al. 2015; Gregorio et al. 2017) (Fig.”
BackgroundRhodopsin–transducin heteropentamer: Three-dimensional structure and biochemical characterization
Jastrzebska, B., Ringler, P., Lodowski, D. T., Moiseenkova-Bell, V., Golczak, M., Müller, S. A., Palczewski, K., & Engel, A. (2011) · Journal of Structural Biology · doi:10.1016/j.jsb.2011.08.016 · Cited by 57
“, 2006), the interaction site between Rho and the Gt C-terminus structurally defined (Choe et al., 2011; Scheerer et al., 2008; Standfuss et al., 2011), and the Gta activation by Rho⁄ characterized by site-directed spin labeling and spectroscopy (Van Eps et al.”
The quest to understand heterotrimeric G protein signaling
Tesmer, J. J. G. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0610-650 · Cited by 57
Владимирович, С. А., Salgado, G. F. J., & Brown, M. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014692108 · Cited by 57
“Crystal structures of ligand-free opsin (19) with a bound synthetic Gt peptide (20) show an elongation of the protein (21, 22) due to helical displacements (19)—but opsin does not contain the activating all-trans-retinal ligand, and its activity does not match rhodopsin (20).”
BackgroundMethodInfluentialOhuchi, H., Yamashita, T., Tomonari, S., Fujita-Yanagibayashi, S., Sakai, K., Noji, S., & Shichida, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031534 · Cited by 60
“Mutation in the glutamic acid/aspartic acid leads to a constitutive active state of rhodopsin family GPCRs [25,26,27].”
InfluentialTosh, D. K., Phan, K., Gao, Z., Gakh, A. A., Xu, F., Deflorian, F., Abagyan, R. A., Stevens, R. C., Jacobson, K. A., & Katritch, V. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300095s · Cited by 56
Comparative Modeling: The State of the Art and Protein Drug Target Structure Prediction
Liu, T., Tang, G. W., & Capriotti, E. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795767811 · Cited by 65
“Although structural understanding of GPCRs has benefited from a number of recent breakthroughs [129-133], coverage of the superfamily’s phylogenetic tree is still incomplete.”
Background
Metadata
- Authors
- Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Queen Mary University of London (GB)
- Humboldt-Universität zu Berlin (DE)
- Corresponding author
- Choe, Hui-Woog
- Hofmann, Klaus Peter
- Ernst, Oliver P.
- ORCID
- Venue
- Nature
- Published
- 2008-09
- Volume
- 455
- Issue
- 7212
- Pages
- 497-502
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989971979
- Cited by
- 1,059
- References
- 64
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 10 · 2023: 12 · 2022: 19 · 2021: 27 · 2020: 19 · 2019: 39 · 2018: 46 · 2017: 54 · 2016: 52 · 2015: 78 · 2014: 64 · 2013: 101 · 2012: 103
- FWCI
- 56.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- HZB Repository (Helmholtz-Zentrum Berlin für Materialien und Energie GmbH (HZB)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Photoreceptor and optogenetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- opsin, rhodopsin, G protein-coupled receptors, G protein activation, G-protein binding site, beta-turn, NPxxY motif, retinal binding site, signal transduction mechanism
- MeSH terms
- Animals, Arginine, Binding Sites, Cattle, Crystallization, Models, Biological, Models, Molecular, Protein Conformation, Regeneration, Retinaldehyde, Rhodopsin, Signal Transduction, Conserved Sequence, Rod Opsins, Crystallography, X-Ray, Amino Acid Motifs, GTP-Binding Protein alpha Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.